Engdahl E, et al. Serological response against HHV-6A is associated with increased risk for multiple sclerosis. Abstract 222. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Langetermijnuitkomsten na stamceltransplantatie bij MS
feb 2017 | Multipele Sclerose